| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 416.0K | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Kaiser Peter | Chief Development Officer | Sell | 9,653 | $11.03 | $106,472.59 | -4.7% | +9.8% | - | |
| Oct 2, 2025 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 10,502 | $11.04 | $115,942.08 | -4.0% | +9.8% | - | |
| Sep 2, 2025 | Notman Donald | See Remarks | Sell | 1,066 | $12.43 | $13,250.38 | -0.3% | -7.8% | - | |
| Aug 25, 2025 | Kaiser Peter | Chief Development Officer | Sell | 3,011 | $12.04 | $36,252.44 | -1.5% | +1.9% | - | |
| Aug 25, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,885 | $12.04 | $22,695.40 | -0.7% | +1.9% | - | |
| Aug 25, 2025 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 3,063 | $12.04 | $36,878.52 | -1.2% | +1.9% | - | |
| Aug 25, 2025 | Dugel Pravin | See Remarks | Sell | 21,494 | $12.04 | $258,787.76 | -0.7% | +1.9% | - | |
| Jun 2, 2025 | Waheed Nadia | Chief Medical Officer | Sell | 13,861 | $8.05 | $111,581.05 | -6.3% | +56.6% | +11.1% | |
| May 23, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,862 | $7.17 | $13,350.54 | -0.7% | +66.2% | +12.7% | |
| May 23, 2025 | Kaiser Peter | Chief Development Officer | Sell | 2,974 | $7.17 | $21,323.58 | -1.4% | +66.2% | +12.7% |